ELANE and chronic purulent otitis media: In conjunction with the fluoroquinolone antibiotic ofloxacin, the current standard of care for CSOM in humans, we treated mice with GW 311616A, a neutrophil elastase inhibitor and examined the impact of these regimens on bacterial load via IVIS and bacterial enumeration.